Antonio Parrado

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2020-2021
Publications (10 Years): 4

Top Topics

Risk Assessment

Top Venues

Antibodies (Basel, Switzerland)

Journal of clinical medicine

Molecular biology reports

This page only lists publications with an associated author ORCID identifier.

Publications

Natalia Ruiz-Lafuente, Alfredo Minguela, José María M Moraleda, Manuel Muro, Antonio Parrado
Variable Distribution of DOCK-D Proteins between Cytosol and Nucleoplasm in Cell Lines, Effect of Interleukin-4 on DOCK10 in B-Cell Lymphoid Neoplasms, and Validation of a New DOCK10 Antiserum for Immunofluorescence Studies. Antibodies (Basel, Switzerland) 10 (3) (2021)
Rafael Alfaro, Isabel Legaz, Victor Jimenez-Coll, Jaouad El Kaaoui El Band, Helios Martínez-Banaclocha, José Antonio Galián, Antonio Parrado, Anna Mrowiec, Carmen Botella, María Rosa Moya-Quiles, Francisco Boix, Jesús de la Peña-Moral, Alfredo Minguela, Santiago Lorente, Manuel Muro
MicroRNA Expression Changes in Kidney Transplant: Diagnostic Efficacy of miR-150-5p as Potential Rejection Biomarker, Pilot Study. Journal of clinical medicine 10 (13) (2021)
Natalia Ruiz-Lafuente, Alfredo Minguela, Manuel Muro, Antonio Parrado
The roles of Cdc42 and Rac1 in the formation of plasma membrane protrusions in cancer epithelial HeLa cells. Molecular biology reports 48 (5) (2021)
Antonio Parrado
Expression of DOCK9 and DOCK11 Analyzed with Commercial Antibodies: Focus on Regulation of Mutually Exclusive First Exon Isoforms. Antibodies (Basel, Switzerland) 9 (3) (2020)